Immunotherapy for gastrointestinal malignancies. - Wikidata - wikimedia - TriplyDB

Immunotherapy for gastrointestinal malignancies.

Immunotherapy for gastrointestinal malignancies.

http://www.wikidata.org/entity/Q36602174

about

Immune response, safety, and survival and quality of life outcomes for advanced colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell therapy Treatment of early gastric cancer in the Western World.Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors.Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors.Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics.Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.Immunotherapy in Gastrointestinal Cancers.Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary Malignancies Chemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis

P2860

Q21284687-6DA970A9-9666-4DE4-A024-5C3199F06D6F Q33626791-ECB63EC8-34FA-49C5-823F-0439E0B684DC Q33949465-F1A70766-709C-456D-B663-589427C7FE47 Q34048027-42FC095D-9B8B-4DC2-A45C-DFEAA005487D Q34402325-B1925E9C-1BBA-48B2-B9AD-8756705ACC7E Q36820371-44513C20-A9B2-40AA-B6E5-E10B30789AB6 Q36946662-9AFE6EDF-A826-4029-B20B-2844FB6A63E2 Q37704879-E10DE783-E094-49D3-9D43-4492C7C2DAD2 Q38886353-96EC4F2C-4E64-49F8-B412-421C3B653A6A Q47104354-5B27DFA2-C55E-4BDC-A2DF-FA12867F4A88 Q53183990-0EBF2AF2-FF03-499E-AE91-71243370DAAF Q56896166-12A69798-DB86-4364-B093-F5B12BCB5F94 Q59125672-0E3D6883-1729-4F9B-8CDC-1C4E21C180B6

P2860

Immunotherapy for gastrointestinal malignancies.

http://www.wikidata.org/entity/Q36602174

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Immunotherapy for gastrointestinal malignancies.

@ast

Immunotherapy for gastrointestinal malignancies.

@en

type

label

Immunotherapy for gastrointestinal malignancies.

@ast

Immunotherapy for gastrointestinal malignancies.

@en

prefLabel

Immunotherapy for gastrointestinal malignancies.

@ast

Immunotherapy for gastrointestinal malignancies.

@en

P1433

Q36602174-933FF908-BF73-4F9B-B7DD-0B66BCAA5935

P1476

Q36602174-C81C7CB2-448B-405D-8656-F04BF52EA8DC

P2093

Q36602174-524F65FE-1031-45AF-A1A8-861A9F058606

Q36602174-68958AFB-278E-44BD-80DF-7F5CB660F67F

Q36602174-7B6381F6-A9CC-40DA-A057-09410C0C9381

Q36602174-967D3FE5-9F33-4468-B884-D64054286475

Q36602174-A9E186D3-F81E-4DEB-A4F6-1B364EEA0DA8

P2860

Q36602174-00E0A169-DCE6-49D0-B1FF-FDAF452E4A28

Q36602174-0148BBC1-2247-4E27-AD79-7739C1340D43

Q36602174-02E196A0-77C0-4200-A0D0-E19CA08AA2D3

Q36602174-04FFBB77-6C15-4F90-9B04-88D1DD389152

Q36602174-071F8496-E4EF-43AB-8BDB-88639669896F

Q36602174-079BF417-A786-4E12-A1DC-0FB09A6798FC

Q36602174-0A9563CF-1AB5-4ACC-8F89-5AAA3D2F623A

Q36602174-0E1CF39F-046D-4459-9F52-013901A6852F

Q36602174-114EF0F0-B03C-4868-93D5-1223E1B68E15

Q36602174-121E5FFC-12E6-45A2-9F9B-F7128569EB2E

P304

Q36602174-7F3707A7-9E05-4FE0-9B78-0871538133EA

P31

Q36602174-CC6D6611-AEC3-450D-B70A-DDBC3638EACD

P356

Q36602174-3D738F0A-6D01-4A33-B460-61B9D8185755

P433

Q36602174-C2F491AA-1EA9-4EDD-905D-48299C1C89FD

P478

Q36602174-B9F0B319-29B6-40DA-8ED6-677B264B8248

P577

Q36602174-52539F58-8852-47B1-8A1F-07FA7FA6BC48

P698

Q36602174-324712C3-9A6B-499D-B3C2-BB235C4D7538

P932

Q36602174-9A3660DF-68B7-4C5B-8AC9-EB403D6CABC9

P356

107327481302000106

P1433

P1476

Immunotherapy for gastrointestinal malignancies.

@en

P2093

Amod A Sarnaik

http://www.w3.org/2001/XMLSchema#string

Nasreen A Vohra

http://www.w3.org/2001/XMLSchema#string

Paul G Toomey

http://www.w3.org/2001/XMLSchema#string

Shari A Pilon-Thomas

http://www.w3.org/2001/XMLSchema#string

Tomar Ghansah

http://www.w3.org/2001/XMLSchema#string

P2860

Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy

Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

Circulating mesothelin protein and cellular antimesothelin immunity in patients with pancreatic cancer

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

P304

32-42

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/107327481302000106

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23302905

http://www.w3.org/2001/XMLSchema#string

P932

4761871

http://www.w3.org/2001/XMLSchema#string